Company Profile
Endo Pharmaceuticals is a specialty pharmaceutical company with a broad portfolio
of branded and generic prescription products to treat pain. Its research and development
programs are focused on finding innovative new drugs to address unmet medical needs
in pain management and other therapeutics areas.
The company’s pain franchise includes LIDODERM® (lidocaine patch 5%), FROVA®
(frovatriptan succinate) tablets, and PERCOCET® (oxycodone and acetaminophen tablets USP) CII, as well as newer products OPANA ER® (oxymorphone HCl) CII extended-release tablets, OPANA®
(oxymorphone HCl) CII immediate-release tablets and VOLTAREN® GEL (diclofenac sodium topical gel) 1%.
Endo was established in 1997 through a management buyout from DuPont Merck. The company based in Chadds Ford, PA and employs more than 1,200 employees throughout the U.S.
